Abstract Changes in hematocrit and plasma oncotic pressure were measured continuously during and after isotonic volume expansion in splenectomized dogs in order to test the potential of these types of measurements to predict changes in plasma volume. A volume of Ringer's solution amounting to l5° of the initial blood volume was infused over 10 min. At the end of the infusion, 54% of infused fluid remained within the intravascular space and 9% of the infused volume was retained within the intravascular space at 50 min after the end of the infusion. Hematocrit and plasma oncotic pressure decreased by 2.4% and 2.4 mmHg, respectively, at the end of infusion and then variables returned to their control levels gradually. Changes in plasma volume were estimated indirectly from hematocrit and plasma oncotic pressure based on the dilution of the erythrocytes and the protein. Highly significant correlations were observed between the measured plasma volume (Y) and the plasma volume (X) calculated from hematocrit (Y= 0.95X+ 0.22, r = 0.96) and the plasma oncotic pressure (Y= 0.86X+ 0.46, r=0.91). We therefore conclude that either hematocrit and plasma oncotic pressure measured continuously are reliable parameters for predicting the time course of the plasma volume change during an isotonic volume expansion of up to 15 of the initial blood volume.
Abstract Changes in hematocrit and plasma oncotic pressure were measured continuously during and after isotonic volume expansion in splenectomized dogs in order to test the potential of these types of measurements to predict changes in plasma volume. A volume of Ringer's solution amounting to l5° of the initial blood volume was infused over 10 min. At the end of the infusion, 54% of infused fluid remained within the intravascular space and 9% of the infused volume was retained within the intravascular space at 50 min after the end of the infusion. Hematocrit and plasma oncotic pressure decreased by 2.4% and 2.4 mmHg, respectively, at the end of infusion and then variables returned to their control levels gradually. Changes in plasma volume were estimated indirectly from hematocrit and plasma oncotic pressure based on the dilution of the erythrocytes and the protein. Highly significant correlations were observed between the measured plasma volume (Y) and the plasma volume (X) calculated from hematocrit (Y= 0.95X+ 0.22, r = 0.96 ) and the plasma oncotic pressure (Y= 0.86X+ 0.46, r=0.91) . We therefore conclude that either hematocrit and plasma oncotic pressure measured continuously are reliable parameters for predicting the time course of the plasma volume change during an isotonic volume expansion of up to 15 of the initial blood volume. K. MIKI et al. ( GILMORE, 1984) . Atrial pressure, which is likely to be a function of circulating blood volume, has been emphasized particularly in these studies (GAUER and HENRY, 1976) . It has been shown clearly that fluid infused into the intravascular space is filtered mainly to the interstitial space within 1 h after administration (TANAKA, 1979) . Therefore, the neural afferent activity involved in volume regulation might be altered as a function of changing levels of plasma volume. However, relatively little attention has been paid to the actual patterns of the changes in blood volume produced by the experimental intervention in previous studies. In this regard, it would be useful to measure simultaneously the actual changes in both the circulating blood volume and cardiovascular parameters involved in the regulation of body fluid volume. Red blood cells or plasma albumin labeled with isotopes have been used for the determination of circulating blood volume based on tracer dilution theory (ALBERT, 1971) . However, there are usually limitations to using isotopes in many laboratories because of the radiation protection problems. Therefore, the techniques for estimating blood volume without using isotopes should be useful for the study of body fluid regulation. We have previously developed methods for continuous measurement of circulating blood volume, hematocrit, and plasma oncotic pressure during body fluid modification (TANAKA et al., 1976) , by volume expansion (MIKI et al., 1983a, b; TANAKA, 1979) , hemorrhage or blood transfusion (MIKI, 1981; MORIMOTO et al., 1981) . In the present study, plasma volume was estimated indirectly from changes in hematocrit (Hct) and plasma oncotic pressure in a continuous manner during isotonic volume expansion (15°c of blood volume) and the values were compared with the plasma volume measured by the 51 Crerythrocytes dilution method.
METHODS
Acute experiments were carried out on ten mongrel male dogs weighing 7.6-14 kg. All dogs were splenectomized at least 1 week prior to the investigation because dogs are known to contract their spleens mobilizing additional red blood cells in response to stress. In this study, splenectomized dogs showed constancy of red cell volume throughout the experiment. On study days, anesthesia was induced with thiopental sodium (25 mg/kg). Each dog was weighed, placed in the supine position on a water mat warmed by temperature-controlled circulating water, intubated, and ventilated with 1-2% halothane in 30% 02-70% N20 with a Harvard-type respirator. Heparin sodium was administered at an initial dose of 5 mg/kg and thereafter at a maintenance dose of 2.5 mg/(kg . h).
Blood volume, Hct, and plasma colloid osmotic pressure were monitored continuously (TANKA et al., 1981) . Briefly, catheters were inserted into the right femoral artery and vein to establish an arterio-venous extracorporeal shunt. Blood was pumped via an extracorporeal circuit which contained a conductivity cell for Hct determination (TANAKA et al., 1976) , a well-type y-counter for continuous PLASMA VOLUME DURING VOLUME EXPANSION 689
determination of blood volume (using the dilution method of 51Cr-labeled red blood cells), and a needle-type oncotic pressure probe for plasma colloid osmotic pressure determination (KAKIUCHI et al., 1980) which uses a hollow fiber (CSP, Asahikasei Co., Japan) as a semipermeable membrane, and returned to the animal. The outflow from the y-detector tube was drained into a small reservoir which contained a liquid level detector. The blood level of this reservoir was fixed at a constant level by adjusting the flow rate of the outlet pump using an analog servo-system. At 10-min intervals, 150-pl arterial blood samples were drawn for determinations of Hct and plasma protein concentrations by the refractometric methodology. The Hct reading of each arterial sample was done in triplicate and the microcentrifugation method was used to calibrate the continuous determination of the Hct. A correction factor of 0.97 was used for trapped plasma. Plasma volume was calculated from the blood volume and Hct.
Infusion of lactated Ringer solution was begun after a 10-min control period. The volume of the infusion was 1500 of the measured circulating blood volume and was administered intravenously at a constant rate over 10 min. The infused volume averaged 10.1 + 2.3 ml/kg. Following completion of the infusion, 50 min were allowed for recovery.
The estimation of plasma volume from the changes in hematocrit ( VAN BEAUMONT, 1972; MIKI et al., 1980; HARRISON, 1985) and plasma colloid osmotic pressure was achieved by the following procedures; when the initial red cell volume and plasma volume are expressed as RCV(0) and PV(0), the initial hematocrit (Hct(0)) can be expressed as
and Hct at time t can be expressed as
Since the red cell volume remains constant during an infusion of an isotonic solution, the initial red cell volume (RCV (0)) is equal to the red cell volume at a given time (RCV(t)) which is written as:
From Eqs. (1), (2), and (3), plasma volume at a given time (PV(t)) can be expressed as:
Plasma protein has also been used for the determination of plasma volume since it is a tracer which distributes throughout the intravascular space. Since plasma oncotic pressure depends on the number of the protein .molecules, the plasma protein concentration can be estimated from plasma oncotic pressure. LANDIS and PAPPENHEIMER (1963) provided a 3-order polynomial equation which allows for the estimation of plasma oncotic pressure ("pi) from plasma protein concentration (Cp) as follows:
II p1= 2. l x Cp + 0.16 x Cpl + 0.009 x Cp3 ,
where Cp (g/100 ml) is plasma protein concentration. Plasma protein concentraion was estimated from plasma oncotic pressure by solving Eq. (5) according to the Newton's method (GERALD and WHEATLEY,1984) . Intravascular protein mass is the product of plasma protein concentration multiplied by plasma volume. The initial intravascular protein mass (IVPM(0), g) is expressed as:
and intravascular protein mass at a given time is expressed as:
Under conditions where the change in intravascular protein mass is negligibly small and IVPM(0) is equal to IVPM(t), plasma volume at a give time (PV(t)) can be estimated by the following equation:
RESULTS
Representative changes in plasma and red cell volumes and Hct are shown in Fig, 1 . The infused fluid shifted from the vascular space into extravascular space immediately after the start of infusion and this shift continued until a new equilibrium state was reached. The volume of fluid retained within the intravascular space was 5.5 + 1.0 ml/kg or 54% of infused volume immediately at the end of infusion and 0.9 + 1.9 ml/kg and 9 % of infused volume 50 min after the end of the infusion. While the red cell volume remained unchanged, the Hct had changed as a function of the changes in plasma volume. At the end of the infusion, the Hct had decreased by 2.4% (Hct unit) and then it increased gradually. Figure 2 shows the time courses of the changes in plasma oncotic pressure, plasma protein concentration, and intravascular protein mass before, during, and following completion of the infusion. Plasma oncotic pressure showed a similar pattern as Hct, decreasing by 2.4 mmHg at the end of infusion and then leveling off at a level which was 0.3 mmHg lower than the control value 50 min after the end of the infusion. Plasma protein concentration was calculated from the plasma oncotic pressure in a continuous manner according to Eq. (5). The absolute values of the plasma protein concentration estimated from plasma oncotic pressure were lower by 0.2 g/100 ml than those measured with refractometry. However, the relative changes in plasma protein concentration from the control level were almost identical when the values estimated with refractometry were compared with those PLASMA VOLUME DURING VOLUME EXPANSION 691 calculated from plasma oncotic pressure. Intravascular protein mass remained unchanged throughout the experiment. The changes in plasma volume estimated from the Hct values were compared with the plasma volume measured using the 51Cr-red blood cell method (Fig. 3) . A PLASMA VOLUME DURING VOLUME EXPANSION 693 from plasma oncotic pressure (Y= 0.86X+ 0.46, r=0.91) was also observed. The time courses of the estimated changes in plasma volume calculated from the Hct and plasma oncotic pressure, occurring during and after the infusion, are plotted in Fig.  5 together with the change in plasma volume measured by 51Cr-labeled red blood cell dilution method as shown in Fig, 1 . The measured values using the 51Cr-labeled red blood cell method and the values calculated from plasma oncotic pressure and Hct coincide very well. In Fig. 6 , the relationship between body weight (from 7.6 to 13 kg) and the initial circulating blood volume is shown using pooled data obtained from our laboratory (Mnu et al., 1983a (Mnu et al., , b, 1984 MORIMOTO et al., 1981; TANAKA, 1979) . A significant linear relationship between body weight (X) and blood volume (Y) (Y= 60.6X+ 4.2, r=0.81) was observed.
DISCUSSION
Continuous measurements of both Hct and plasma oncotic pressure were used to calculate the changes in plasma volume continuously during volume expansion.
The calculated plasma volumes were compared with plasma volume measured by the 51Cr-erythrocyte dilution method.
In order to use Hct to estimate the changes in plasma volume, it must be certain that mean corpuscular volume is not altered in responses to the stimuli which induce the changes in plasma volume (HARRISON, 1985) . In the present study, red cell volume remained constant throughout the experiment. A significant linear relationship with a high correlation was obtained between the changes in measured plasma volume and the estimated plasma volume obtained from the change in Hct during isotonic fluid infusion (Fig. 3) . This observation allows us to conclude that Hct is a reliable parameter for estimating changes in plasma volume in a quantitative manner during isotonic volume expansion. Another experimental maneuver in which red cell volume remained unchanged is head-out water immersion. This procedure causes a sustained and significant fluid movement from extravascular into intravascular space while plasma osmolality remains constant (MIKI et al., 1986) . Recently, BuoNo and FAUCIER (1985) reported that the human erythrocyte in vivo does not always behave like a perfect osmometer. They demonstrated that the human erythrocyte has an ability to increase its osmolality in vivo to match that of the plasma such that erythrocyte volume remains relatively unchanged during exercise despite a significant increase in plasma osmolality during exercise. Thus, Hct is likely to be useful for estimating plasma volume under the condition in which either plasma osmolality remains constant or increases within physiological ranges. PLASMA VOLUME DURING VOLUME EXPANSION 695
Since oncotic pressure is determined by the number of protein molecules, it is expressed by Eq. (5) as a function of plasma protein concentration. In the present study, continuous measurement of plasma oncotic pressure was used to estimate the plasma protein concentration continuously. As is shown in Fig. 2 , plasma protein concentrations estimated from plasma oncotic pressure were in agreement with those measured by the refractometirc method. Intravascular protein content stayed constant during the infusion. Therefore, the change in plasma protein concentration during infusion is due to changes in plasma volume and a significant relationship between the estimated change in plasma volume from oncotic pressure and the measured value of plasma volume is obtained (Fig. 4) . However, the regression coefficient obtained between the change in measured plasma volume and the plasma volume estimated from plasma protein concentration is lower than that obtained between the measured plasma volume and plasma volume estimated from Hct. This is probably due to the error which occurs in the process of estimating plasma protein concentration from oncotic pressure. It has been reported that changes in plasma electrolytes concentrations or pH alter plasma oncotic pressure (MIKI et al., 1983a, b) . In the present study, intravascular protein content remained constant during infusion. However, changes in intravascular protein content occur following hemorrhage or blood transfusion (MIKI et a!., 1984) and in these cases, prediction of plasma volume from the plasma oncotic pressure would not be recommended. Continuous measurement of Hct or plasma oncotic pressure allows us to estimated plasma volume in a continuous manner with only a minimum blood loss for the purpose of calibration of the conductivity cell for Hct. As shown in Fig. 1 , the infused fluid moved to extravascular space immediately after the start of infusion. In order to study relationships between the absolute change in plasma volume and cardiovascular-renal functions, such as urine flow or renal sympathetic nerve activity, plasma volume should be measured at as many points as possible. However, repeated blood sampling for the measurement of Hct or plasma protein concentration causes a significant loss of circulating blood volume. Miiu et al. (1980) noted measurable decreases in circulating blood volume when total blood withdrawal for the measurement of Hct or plasma protein concentration was over 3 % of initial circulating blood volume. For instance, 1.8 ml/kg is the maximum blood volume which will not have a significant influence on circulating blood volume in dogs.
In conclusion, it is demonstrated that the infused fluid started to shift to the extravascular space immediately after the start of infusion. The continuous measurements of Hct and plasma oncotic pressure provide us with the time course of the changes in plasma volume following the infusion with minimum blood loss for sampling purposes. The use of this method under the specific experimental Relationship between blood volume and body weight ranging from 7.6 to 14 kg. Data are adopted from studies previously reported from our laboratory.
PLASMA VOLUME DURING VOLUME EXPANSION 697 conditions described in this study may obviate the requirement to use radioisotope techniques in certain studies.
